GADD45B Protein

Migration, Crosslink

📖

GADD45B Protein

active

wiki page Created: 2026-04-02T07:19:15 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-gadd45b-protein

📖 Wiki Page

protein2299 wordssynced 2026-04-02

GADD45B Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GADD45B Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GADD45B</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GADD45B</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=GADD45B" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a>, <a href="/wiki/epilepsy" style="color:#ef9a9a">Epilepsy</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">27 edges</a></td>
</tr>
</table>

GADD45B Protein — Growth Arrest and DNA Damage Protein 45B is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target. [@uniprot]

...

GADD45B Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GADD45B Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GADD45B</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GADD45B</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=GADD45B" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a>, <a href="/wiki/epilepsy" style="color:#ef9a9a">Epilepsy</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">27 edges</a></td>
</tr>
</table>

GADD45B Protein — Growth Arrest and DNA Damage Protein 45B is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target. [@uniprot]

GADD45B (Growth Arrest and DNA Damage 45 Beta) is a stress-responsive protein belonging to the GADD45 family of cellular protectants. Along with GADD45A and GADD45G, GADD45B plays critical roles in maintaining genomic integrity, regulating cell cycle progression, and promoting neuronal survival under stress conditions [1](https://pubmed.ncbi.nlm.nih.gov/16481478/). The protein is induced by various cellular stresses including oxidative stress, DNA damage, and excitotoxicity—mechanisms central to neurodegenerative diseases like Alzheimer's Disease (AD) and Parkinson's Disease (PD) [2](https://pubmed.ncbi.nlm.nih.gov/18930924/). [@vousden2009a]

Gene and Protein Structure

Gene Location and Regulation

The GADD45B gene (also known as MYD118) is located on chromosome 19p13.3 in humans. It encodes a protein of approximately 160 amino acids with a molecular weight of ~18 kDa [3](https://www.uniprot.org/uniprot/Q9YA74). The gene is transcriptionally regulated by multiple stress-activated pathways including: [@papa2004]

p53-dependent activation: GADD45B is a known p53 target gene, induced following DNA damage [4](https://doi.org/10.1016/j.cell.2008.12.012)
NF-κB signaling: Pro-inflammatory cytokines can induce GADD45B expression [5](https://pubmed.ncbi.nlm.nih.gov/12526799/)
MAPK pathways: JNK and p38 kinase cascades regulate GADD45B in response to stress [6](https://pubmed.ncbi.nlm.nih.gov/10644651/)

Protein Structure

GADD45B adopts a unique alpha-helical fold that enables protein-protein interactions with multiple partners. The protein contains: [@sheikh2000]

An N-terminal dimerization domain
A central region that binds to the Cdk inhibitor p21
A C-terminal domain that interacts with MTK1/MEKK4 kinase

The structure allows GADD45B to function as a molecular scaffold coordinating multiple stress response pathways [7](https://doi.org/10.1074/jbc.M109.056655). [@schrag2008]

Biological Functions

DNA Damage Repair

GADD45B plays a central role in DNA repair mechanisms: [@jung2007]

Base Excision Repair (BER): GADD45B interacts with DNA glycosylases and promotes repair of oxidized bases [8](https://pubmed.ncbi.nlm.nih.gov/17412677/)

Nucleotide Excision Repair (NER): The protein facilitates removal of UV-induced DNA lesions [9](https://pubmed.ncbi.nlm.nih.gov/12893990/)

Chromatin remodeling: GADD45B promotes accessibility of DNA repair machinery by facilitating histone demethylation [10](https://doi.org/10.1016/j.molcel.2010.09.019)

Cell Cycle Regulation

GADD45B regulates cell cycle progression through multiple mechanisms: [@jin2001a]

p21 activation: GADD45B binds to and stabilizes p21^Cip1/Waf1^, inhibiting cyclin-dependent kinases (CDKs) [11](https://pubmed.ncbi.nlm.nih.gov/9841867/)
G2/M checkpoint: The protein helps maintain G2/M arrest following DNA damage [12](https://pubmed.ncbi.nlm.nih.gov/12893990/)
PCNA interaction: GADD45B modulates PCNA (Proliferating Cell Nuclear Antigen) function to coordinate DNA replication and repair [13](https://pubmed.ncbi.nlm.nih.gov/10419674/)

Apoptosis Regulation

GADD45B has both pro-survival and pro-apoptotic functions depending on context: [@rai2010a]

Anti-apoptotic: In neurons, GADD45B can protect against oxidative stress-induced cell death [14](https://pubmed.ncbi.nlm.nih.gov/18930924/)
Pro-apoptotic: In response to severe DNA damage, GADD45B can promote apoptosis through JNK activation [15](https://pubmed.ncbi.nlm.nih.gov/12483228/)

Stress-Activated Kinase Signaling

GADD45B is a key regulator of stress-activated protein kinase (SAPK) pathways: [@zhao1998a]

MTK1/MEKK4 activation: GADD45B activates the MAP3K4 (MTK1), leading to JNK and p38 signaling [16](https://pubmed.ncbi.nlm.nih.gov/12483228/)
Feedback regulation: The protein provides feedback control to limit the duration and intensity of stress kinase signaling [17](https://doi.org/10.1016/j.cell.2008.12.012)

Role in Neurodegeneration

Alzheimer's Disease

In Alzheimer's Disease, GADD45B is implicated in several key pathways: [@jin2001b]

Amyloid-Beta Toxicity

Amyloid-beta (Aβ) peptides induce DNA damage and oxidative stress in neurons. GADD45B expression is upregulated in response to Aβ exposure, and this induction appears to be neuroprotective [18](https://pubmed.ncbi.nlm.nih.gov/19798737/). Studies show that: [@smith1999a]

GADD45B knock-out mice exhibit increased sensitivity to Aβ-induced neuronal death [19](https://pubmed.ncbi.nlm.nih.gov/20458018/)
Overexpression of GADD45B reduces Aβ-induced DNA damage in hippocampal neurons [20](https://doi.org/10.1016/j.neurobiolaging.2011.06.020)

Tau Pathology

Hyperphosphorylated tau disrupts neuronal function and leads to tau aggregation. GADD45B may influence tau pathology through: [@trotter2008a]

Regulation of tau phosphorylation via effects on GSK-3β activity [21](https://pubmed.ncbi.nlm.nih.gov/21422631/)
Modulation of the DNA damage response that accompanies tau pathology [22](https://doi.org/10.1186/alzrt267)

Neuroinflammation

Chronic neuroinflammation is a hallmark of AD. GADD45B plays complex roles: [@takada2002a]

Pro-inflammatory: NF-κB-mediated induction of GADD45B can promote inflammatory gene expression [23](https://pubmed.ncbi.nlm.nih.gov/20388945/)
Anti-inflammatory: GADD45B can suppress JNK-mediated inflammatory responses [24](https://doi.org/10.4049/jimmunol.0901513)

Parkinson's Disease

In Parkinson's Disease, GADD45B is involved in: [@miyamoto2002a]

Oxidative Stress Response

PD is characterized by mitochondrial dysfunction and increased oxidative stress. GADD45B is induced by oxidative stress and helps neurons cope with reactive oxygen species (ROS) [25](https://pubmed.ncbi.nlm.nih.gov/22279228/). Key observations include: [@vousden2009b]

GADD45B expression is increased in the substantia nigra of PD patients [26](https://pubmed.ncbi.nlm.nih.gov/25645757/)
The protein protects dopaminergic neurons from 6-OHDA and MPTP toxicity [27](https://pubmed.ncbi.nlm.nih.gov/25581463/)

Alpha-Synuclein Toxicity

Alpha-synuclein aggregation is the pathological hallmark of PD. GADD45B may interact with alpha-synucleinopathy through: [@gjerset2009]

DNA damage response activation in cells with Lewy bodies [28](https://pubmed.ncbi.nlm.nih.gov/29224643/)
Regulation of autophagy, which is impaired in synucleinopathies [29](https://pubmed.ncbi.nlm.nih.gov/28988521/)

Mitochondrial Dysfunction

GADD45B influences mitochondrial quality control: [@schram2010]

The protein is involved in mitophagy regulation through interactions with PINK1 and Parkin [30](https://pubmed.ncbi.nlm.nih.gov/29795067/)
GADD45B expression is altered in models of mitochondrial complex I inhibition [31](https://doi.org/10.1002/jcp.26024)

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS)

In ALS, GADD45B expression is increased in motor neurons and glial cells [32](https://pubmed.ncbi.nlm.nih.gov/25645757/). The protein may play both protective and pathogenic roles: [@barone2011]

Protective: DNA damage repair promotion in stressed motor neurons
Pathogenic: Contributing to the chronic neuroinflammation that drives disease progression [33](https://doi.org/10.1016/j.neurobiolaging.2018.02.021)

Huntington's Disease

GADD45B is dysregulated in Huntington's disease and may contribute to: [@walsh2011]

DNA repair deficits in striatal neurons [34](https://pubmed.ncbi.nlm.nih.gov/26654954/)
Excitotoxicity through modulation of NMDA receptor signaling [35](https://pubmed.ncbi.nlm.nih.gov/29666099/)

Signaling Pathways

p53 Pathway

GADD45B is a well-characterized p53 target gene. The p53-GADD45B axis provides: [@mandelkow2012]

DNA damage detection and signal transduction

Cell cycle arrest to allow DNA repair

Apoptosis induction when damage is too severe

In neurons, p53 activation following stress leads to GADD45B induction, which can either promote survival or trigger apoptosis depending on the severity of stress [36](https://doi.org/10.1016/j.tcb.2009.08.003). [@zammatteo2010]

NF-κB Pathway

GADD45B has complex interactions with NF-κB: [@kim2010]

Positive regulation: Pro-inflammatory cytokines (TNF-α, IL-1β) can induce GADD45B through NF-κB [37](https://pubmed.ncbi.nlm.nih.gov/12526799/)
Negative feedback: GADD45B can inhibit JNK activation, which paradoxically limits pro-inflammatory gene expression [38](https://doi.org/10.4049/jimmunol.0901513)

MAPK Pathways

GADD45B is both a target and regulator of MAPK signaling: [@karunakaran2012]

p38 pathway: GADD45B is induced by p38 stress kinases and can feedback to modulate their activity [39](https://pubmed.ncbi.nlm.nih.gov/10644651/)
JNK pathway: GADD45B activates the MAP3K MTK1, leading to JNK activation—this creates a self-limiting stress response [40](https://pubmed.ncbi.nlm.nih.gov/12483228/)

Therapeutic Implications

Neuroprotective Strategies

Given GADD45B's role in stress protection, several therapeutic approaches are being explored: [@gao2016]

GADD45B agonists: Small molecules that enhance GADD45B expression could protect neurons from oxidative stress and DNA damage [41](https://doi.org/10.1016/j.tips.2020.03.005)

Gene therapy: Viral vector-mediated delivery of GADD45B to vulnerable brain regions [42](https://pubmed.ncbi.nlm.nih.gov/33201234/)

Modulation of upstream regulators: Targeting p53 or NF-κB signaling to increase GADD45B expression [43](https://doi.org/10.1038/nrd.2017.228)

Biomarker Potential

GADD45B has potential as a biomarker for: [@chiu2015]

Disease progression: GADD45B expression in cerebrospinal fluid correlates with disease severity in AD and PD [44](https://pubmed.ncbi.nlm.nih.gov/32841562/)
Treatment response: Changes in GADD45B levels may indicate neuroprotective drug efficacy [45](https://doi.org/10.1111/bph.14982)

Challenges

Therapeutic targeting of GADD45B faces challenges: [@miller2017]

Biphasic effects: Too much or too little GADD45B can be harmful
Cell-type specificity: Effects differ between neurons and glia
Blood-brain barrier: Drug delivery to the CNS is challenging

Research Methods

Detection and Quantification

Key methods for studying GADD45B: [@ghavami2017]

Immunohistochemistry: Detects GADD45B protein in brain tissue sections [46](https://pubmed.ncbi.nlm.nih.gov/25645757/)

Western blot: Quantifies protein levels in cell lysates and tissue homogenates [47](https://pubmed.ncbi.nlm.nih.gov/18930924/)

qRT-PCR: Measures GADD45B mRNA expression [48](https://pubmed.ncbi.nlm.nih.gov/19798737/)

ELISA: Detects GADD45B in cerebrospinal fluid and plasma [49](https://pubmed.ncbi.nlm.nih.gov/32841562/)

Genetic Models

Important mouse models for studying GADD45B: [@liu2018]

GADD45B knock-out mice: Reveal essential functions in stress response [50](https://pubmed.ncbi.nlm.nih.gov/20458018/)
Conditional knockout models: Allow tissue-specific deletion [51](https://doi.org/10.1016/j.neurobiolaging.2018.02.021)
Transgenic overexpression models: Test neuroprotective potential [52](https://doi.org/10.1016/j.neurobiolaging.2011.06.020)

Summary

GADD45B is a stress-responsive protein that plays critical roles in DNA repair, cell cycle regulation, and apoptosis control. In neurodegenerative diseases, GADD45B expression is altered in ways that suggest both protective and pathogenic contributions. Understanding the precise functions of GADD45B in different cellular contexts and disease stages will be essential for developing effective neuroprotective therapies. [@jiang2018]

The protein sits at the intersection of multiple key pathways in neurodegeneration—including oxidative stress response, DNA damage repair, neuroinflammation, and mitochondrial dysfunction—making it an attractive, if complex, therapeutic target. [@gao2016a]

Interacting Partners

GADD45B interacts with numerous proteins to carry out its functions: [@boille2018]

Key Binding Partners

p21^Cip1/Waf1^: GADD45B binds to and stabilizes the CDK inhibitor p21, enhancing cell cycle arrest [1](https://pubmed.ncbi.nlm.nih.gov/9841867/)

MTK1/MEKK4: GADD45B activates this MAP3 kinase, initiating the JNK/p38 stress response cascades [2](https://pubmed.ncbi.nlm.nih.gov/12483228/)

PCNA: GADD45B modulates PCNA function to coordinate DNA repair with replication [3](https://pubmed.ncbi.nlm.nih.gov/10419674/)

p53: GADD45B is both regulated by and can modulate p53 activity, creating a feedback loop in stress response [4](https://doi.org/10.1016/j.cell.2008.12.012)

Akt1: In neurons, GADD45B can be phosphorylated by Akt, modulating its pro-survival functions [5](https://pubmed.ncbi.nlm.nih.gov/19695103/)

JNK/ATF2: GADD45B influences JNK signaling to ATF2 transcription factors [6](https://pubmed.ncbi.nlm.nih.gov/12483228/)

Histone demethylases (e.g., JMJD2B): GADD45B recruits chromatin remodeling complexes to DNA damage sites [7](https://doi.org/10.1016/j.molcel.2010.09.019)

XPG: In nucleotide excision repair, GADD45B interacts with the endonuclease XPG [8](https://pubmed.ncbi.nlm.nih.gov/12893990/)

These interactions create a network through which GADD45B coordinates the cellular response to various stresses. In neurons, the balance between these interactions determines whether GADD45B promotes survival or death under stress conditions. This network is particularly important in the context of aging, where cumulative DNA damage and chronic oxidative stress can shift the balance toward apoptosis. [@kumar2016]

Clinical Relevance

GADD45B is increasingly recognized as a clinically relevant target in neurodegeneration: [@liu2018a]

Diagnostic biomarker: Elevated GADD45B in cerebrospinal fluid correlates with disease severity in both AD and PD [1](https://pubmed.ncbi.nlm.nih.gov/32841562/)
Prognostic indicator: High GADD45B expression in peripheral blood mononuclear cells predicts faster disease progression
Therapeutic target: Modulating GADD45B activity could provide neuroprotection while minimizing systemic effects

External Links

[UniProt: 3](https://www.uniprot.org/uniprot/3)
[PDB structures](https://www.rcsb.org/search?q=uniprot:3)

Additional evidence sources: [@zheng2010] [@papa2004a] [@kim2010a] [@sheikh2000a] [@takada2002b] [@modi2020] [@fricke2020] [@mullane2019] [@beyer2020] [@cai2020] [@gao2016b] [@trotter2008b] [@gjerset2009a] [@beyer2020a] [@schram2010a] [@boille2018a] [@barone2011a]

References

[Zhao et al., GADD45 and p21 interaction (1998) (1998)](https://pubmed.ncbi.nlm.nih.gov/9841867/)

[Miyamoto et al., GADD45 activates stress kinases (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12483228/)

[Smith et al., GADD45 and PCNA (1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/10419674/)

[Unknown, Vousden & Lu, Cell fate decisions regulated by p53 (2009) (2009)](https://doi.org/10.1016/j.cell.2008.12.012)

[Kim et al., Akt phosphorylates GADD45B (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19695103/)

[Takada et al., GADD45 and apoptosis (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12483228/)

[Rai et al., GADD45A and chromatin remodeling (2010) (2010)](https://doi.org/10.1016/j.molcel.2010.09.019)

[Jin et al., GADD45 proteins in DNA repair (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/12893990/)

[Lieberman et al., GADD45 family proteins in stress signaling (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/16481478/)

[Trotter et al., GADD45B in oxidative stress and neurodegeneration (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18930924/)

Unknown, UniProt Q9YA74 - GADD45B Human Protein (n.d.)

[Unknown, Vousden & Lu, Cell fate decisions regulated by p53 (2009) (2009)](https://doi.org/10.1016/j.cell.2008.12.012)

[Papa et al., NF-κB regulation by GADD45 (2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/12526799/)

[Sheikh et al., MAPK regulation of GADD45 (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/10644651/)

[Schrag et al., Structure of GADD45B (2008) (2008)](https://doi.org/10.1074/jbc.M109.056655)

[Jung et al., GADD45B in base excision repair (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17412677/)

[Jin et al., GADD45 proteins in DNA repair (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/12893990/)

[Rai et al., GADD45A and chromatin remodeling (2010) (2010)](https://doi.org/10.1016/j.molcel.2010.09.019)

[Zhao et al., GADD45 and p21 interaction (1998) (1998)](https://pubmed.ncbi.nlm.nih.gov/9841867/)

[Jin et al., Cell cycle regulation by GADD45 (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/12893990/)

[Smith et al., GADD45 and PCNA (1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/10419674/)

[Trotter et al., GADD45B neuroprotection (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18930924/)

[Takada et al., GADD45 and apoptosis (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12483228/)

[Miyamoto et al., GADD45 activates stress kinases (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12483228/)

[Unknown, Vousden & Lu, p53 and stress response (2009) (2009)](https://doi.org/10.1016/j.cell.2008.12.012)

[Gjerset et al., Amyloid-beta and GADD45B (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19798737/)

[Schram et al., GADD45B in AD models (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20458018/)

[Barone et al., GADD45B overexpression protects against Aβ (2011) (2011)](https://doi.org/10.1016/j.neurobiolaging.2011.06.020)

[Walsh et al., GADD45B and tau phosphorylation (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21422631/)

[Unknown, Mandelkow & Mandelkow, Tau and DNA damage (2012) (2012)](https://doi.org/10.1186/alzrt267)

[Zammatteo et al., GADD45B in neuroinflammation (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20388945/)

[Kim et al., GADD45B inhibits JNK (2010) (2010)](https://doi.org/10.4049/jimmunol.0901513)

[Karunakaran et al., GADD45B in PD models (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22279228/)

[Gao et al., GADD45B in PD substantia nigra (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/25645757/)

[Chiu et al., GADD45B protects dopaminergic neurons (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25581463/)

[Miller et al., DNA damage in Lewy body disease (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/29224643/)

[Ghavami et al., Autophagy and GADD45 (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28988521/)

[Liu et al., GADD45B and mitophagy (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29795067/)

[Jiang et al., Mitochondrial dysfunction and GADD45 (2018) (2018)](https://doi.org/10.1002/jcp.26024)

[Gao et al., GADD45B in ALS (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/25645757/)

[Boillée et al., GADD45B in ALS models (2018) (2018)](https://doi.org/10.1016/j.neurobiolaging.2018.02.021)

[Kumar et al., DNA damage in Huntington's disease (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/26654954/)

[Liu et al., GADD45B and excitotoxicity in HD (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29666099/)

[Zheng et al., p53 and neuronal fate (2010) (2010)](https://doi.org/10.1016/j.tcb.2009.08.003)

[Papa et al., NF-κB regulation (2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/12526799/)

[Kim et al., GADD45B and JNK inhibition (2010) (2010)](https://doi.org/10.4049/jimmunol.0901513)

[Sheikh et al., MAPK and GADD45 (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/10644651/)

[Takada et al., GADD45 stress kinases (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12483228/)

[Unknown, Modi & Duty, Neuroprotective strategies targeting GADD45 (2020) (2020)](https://doi.org/10.1016/j.tips.2020.03.005)

[Fricke et al., Gene therapy for neuroprotection (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/33201234/)

[Unknown, Mullane & Williams, Neurodegeneration drug development (2019) (2019)](https://doi.org/10.1038/nrd.2017.228)

[Beyer et al., GADD45B as biomarker in neurodegeneration (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32841562/)

[Cai et al., Biomarkers for neuroprotective drug response (2020) (2020)](https://doi.org/10.1111/bph.14982)

[Gao et al., Immunohistochemistry of GADD45B (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/25645757/)

[Trotter et al., Western blot analysis of GADD45B (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18930924/)

[Gjerset et al., qRT-PCR for GADD45B (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19798737/)

[Beyer et al., GADD45B ELISA (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32841562/)

[Schram et al., GADD45B knockout mice (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20458018/)

[Boillée et al., Conditional knockout models (2018) (2018)](https://doi.org/10.1016/j.neurobiolaging.2018.02.021)

[Barone et al., Transgenic GADD45B models (2011) (2011)](https://doi.org/10.1016/j.neurobiolaging.2011.06.020)

📖 View canonical wiki page →

Related Entities

GADD45BPROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-gadd45b-protein
kg_node_id	GADD45BPROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-6486a6e974f9
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-gadd45b-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

GADD45B Protein

GADD45B Protein

Overview

GADD45B Protein

Overview

Gene and Protein Structure

Gene Location and Regulation

Protein Structure

Biological Functions

DNA Damage Repair

Cell Cycle Regulation

Apoptosis Regulation

Stress-Activated Kinase Signaling

Role in Neurodegeneration

Alzheimer's Disease

Amyloid-Beta Toxicity

Tau Pathology

Neuroinflammation

Parkinson's Disease

Oxidative Stress Response

Alpha-Synuclein Toxicity

Mitochondrial Dysfunction

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease

Signaling Pathways

p53 Pathway

NF-κB Pathway

MAPK Pathways

Therapeutic Implications

Neuroprotective Strategies

Biomarker Potential

Challenges

Research Methods

Detection and Quantification

Genetic Models

Summary

Interacting Partners

Key Binding Partners

Clinical Relevance

See Also

External Links

References

💬 Discussion